Breaking: UPC hits NanoString with European sales ban

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Breaking: UPC hits NanoString with European sales ban

Munich.jpg

The decision marks the first time the Unified Patent Court has issued a preliminary injunction after an oral hearing involving both sides in a dispute

The Unified Patent Court granted US biotech company 10x Genomics a preliminary injunction against rival NanoString today, September 19, in a major first for the new court.

Presiding Judge Matthias Zigann, who handed down the order, said the UPC would decide on another PI request on October 10.

It was initially expected that there would be a decision on both applications today.

NanoString can challenge today’s decision at the UPC Court of Appeal in Luxembourg.

The order marks the first time the UPC has issued a PI after hearing oral arguments between both parties in a dispute since the court started hearing cases in June.

The UPC previously issued an ex parte injunction in a dispute between Swiss bike manufacturers myStromer and Revolt Zycling.

Today’s order comes after a hearing at the Munich local division on September 6. Sources who attended that hearing had told Managing IP that an injunction was likely.

One of 10x’s lawyers, Bardehle Pagenberg partner Tilman Müller-Stoy, described the judges as among the best-prepared he had seen in his career after the hearing.

Zigann heard the case alongside three other judges – Tobias Pichlmaier, András Kupecz, and Eric Enderlin.

The PI is the second injunction 10x has obtained from a court in Germany against NanoString so far this year.

The Munich Regional Court issued an anti-anti-suit injunction against NanoString in April, believed to be the first order of its kind in a German life sciences suit.

The order forced NanoString to withdraw an anti-suit injunction it had filed at the US District Court for the District of Delaware.

more from across site and SHARED ros bottom lb

More from across our site

VO, which has offices in the Netherlands, Belgium and Germany, is the second European IP firm to secure external backing this week
The Bardehle Pagenberg attorneys-at-law discuss the firm’s Managing IP EMEA Awards 2026 success, Unified Patent Court litigation strategy, and evolving European patent trends
A patent battle between two legal tech companies and a loss for Elon Musk’s xAI against OpenAI were also among the top talking points
With drug prices a hot topic in the US, courts are seemingly more reluctant to prevent the entry of generics to the market
Academic Eden Sarid joins us during Pride Month to discuss queer expression and IP law, Patagonia v Pattie Gonia, and how queer and AI-generated creations both pose novelty concerns
Patent attorney Michael Henson joins the firm to lead its freshly launched blockchain and digital assets practice
A dispute over mammogram technology, and a development in the case between GSK and Moderna were also among the top talking points in recent weeks
With rankings for Western Europe set to be published on June 25, we sat down with our research lead to find out what practitioners and law firms can expect
Peter O’Sullivan, a professional services executive, says he is looking forward to helping Pearce IP become the leading life sciences firm in Australia and New Zealand
Matteo Di Lernia, advocate at LCA Studio Legale, unpicks the CJEU’s ruling in M.M. Ristorazione v Villa Ramazzini, including its impact on litigation strategies
Gift this article